Tender Detail with Corrigendum

Corrigendum - 1 Published On : 08/01/2020
Corrigendum Details :Amendments in BOQ/ technical specification/Eligibility Criteria.
Corrigendum Type :Technical Bid
Corrigendum Document : Available Corrigendum Document For Download
Buyer/Seller : Can be viewed by Subscribers
Ref. Number : 37930724 Tender Number : 2019_RMSCL_173361_1 Tender Prod. No : 2019_RMSCL_173361_1
Requirement : Supply of drug and medicine - lignocaine ointment 5 o/o [9], lignocaine and dextrose injection ip each ml contains lignocaine 50 mg and dextrose (monohydrate) 75 mg[11], morphine sulphate injection ip 10mg/ml, phenytoin injection bp 50mg/ml, sodium valproate ip injection 100 mg/ml, acyclovir tablets ip 800 mg, primaquine tablets ip 2.5 mg, primaquine tablets ip 7.5 mg, quinine sulphate tablets ip 300mg (film coated), cyclophosphamide injection ip 200 mg, melphalan tablets ip 5 mg, mercaptopurine tablets ip 50 mg, vinblastine injection ip 10mg, vincristine injection ip 1 mg , enalapril maleate tablets ip 5mg , isosorbide dinitrate tablets ip 5 mg, nifedipine cap ip 5mg , nitroglycerin injection ip 5 mg/ ml, metoclopramide tablets ip 10 mg, ethinyloestradiol tabs ip 50 mcg, glibenclamide tablets ip 5 mg, hydroxyprogesterone injection ip 250mg/ ml, progesterone injection ip 200 mg/ 2ml, neostigmine tablets ip 15 mg, atropine sulphate ophthalmic solution usp 1%, isoxsuprine injection ip 5 mg/ml, chlorpromazine tablets ip 25 mg (sugar- coated), chlorpromazine inj. ip 25mg/ml, haloperidol tablets ip 5 mg, imipramine tablets ip 25 mg (coated tablets), lorazepam injection ip 2 mg/ml, risperidone tablets 1 mg, salbutamol tablets ip 2 mg, hyaluronidase injection ip each vial contains hyaluronidase ip 1500 i.u. , losartan potassium and hydrochlorothiazide tablets ip(losartan potassium 50 mg, hydochlorothiazide 12.5 mg), losartan tablets ip 25 mg, torsemide injection 10 mg/ml, metoclopramide hydrochloride syrup ip 5 mg/ 5ml, aztreonam for injection usp 500 mg, cefepime injection ip 500 mg, cefuroxime axetil tablets ip 250 mg, alpha interferon injection interferon alpha 2 concentrated solution ip 3 million unit [525], dacarbazine injection 500 mg ip, gemcitabine for injection ip 200 mg, mitomycine injection ip 10 mg , bromocriptine tablets ip 2.5 mg , isoprenaline injection ip 2mg / ml [551], prazosin tablets (extended release) 2.5 mg, povidone iodine solution ip 10%, finasteride tablets ip 5 mg , neomycin, polymixin b and hydrocortisone ear drops (neomycin sulphate 3400 iu, polymixin b sulphate 10000 iu, and hydrocortisone 10 mg per ml) neomycin and polymixin b sulfate and hydrocortisone otic solution usp, glucagon for injection usp 1 mg, phenylephrine eye drops ip 5%, pyridoxine tablets ip 40 mg, surfactant for intratrecheal instillation (natural bovine lung surfactant) , each combi blister pack containing 3 tablet of artesunate (each tablet of artesunate 25 mg strength) and 1 tablet of sulphadoxine pyremethamine (250 mg +12.5 mg), teneligliptin tablet 20 mg, fluconazole tab. ip 150mg, "iron and folic acid syrup ip, each ml of syrup contains ferrous sulphate ip equivalent to elemental ferrous iron 20 mg, folic acid ip 0.1 mg", diagnostic strip for glucose, ketone, diagnostic strip for glucose, protein, capreomycin injection 500 mg, moxifloxacin tablets 400 mg, misoprostol tablets ip 600 mcg, dual rapid test kit for hiv & syphilis, multiple urine analysis strip .

Key Values

Document Fees : 2
EMD : 500,000
Tender Estimated Cost : 441,000,000
Closing Date : 22/01/2020
Document Sale To : 22/01/2020
Location : Rajasthan - India

Value Added Services

  • Get consortium partner
  • Get Winning Estimate
  • Track Tender Result
  • Get Subcontractors
  • Find Liaison Agency
  • Ask Expert

Disclaimer : Tender Tiger takes all possible care to ensure accurate & authentic tender information however it cannot be held responsible for Omissions, Errors, etc. Users are advised to refer to Tender Document published by Procuring entity before they take submit their actual bid.